Press Release Amundi obtains regulatory approval for ICG board seatand will consolidate its stake using the equity method as from 31 March 2026 Paris, 19 February 2026 Amundi announces that it has obtained all regulatory approvals for ICG to appoint an Amundi-nominated director to its Board. Vincent Mortier, Amundi’s Group Chief Investment Officer, will join the Board of ICG as a Non-Executive Director on 31 March 2026. He will also serve as a member of ICG’s Board Nomination and Governance Committee. As a consequence, Amundi will consolidate its stake in ICG using the equity method as from 31 March 2026. In accordance with the partnership announced on 18 November 2025, Amundi currently holds a 4.64% stake in ICG and intends to increase its economic interest to 9.9%, through the issuance of non-voting shares by ICG to Amundi1. About Amundi Amundi,...

Harju Elekter finished the year with strong results. Revenue reached the same level as in 2024, which is in line with the Group’s normal operating volume and orders. The last quarter was the period with the highest revenue of the year and compared to the fourth quarter of the previous year, we were able to turn losses into moderate profits, despite the fact that it is rather a low season for the Group. Over the course of the year, we consistently focused on improving profitability, which has been one of our most important strategic goals. The growth in profitability was supported by informed management decisions – we focused more selectively on projects and solutions where our technical competence creates greater value for the customer and enables better margins to be achieved. The quality of the sales structure and the efficiency...

Well-capitalised HealthTech group enters delivery phase across platform expansion, selective acquisitions and science-led product development LONDON, Feb. 18, 2026 (GLOBE NEWSWIRE) — Rapid Nutrition PLC, a HealthTech company trading on Euronext Growth Paris (ALRPD), provides a strategic outlook update as the Company enters a focused execution phase across its core growth initiatives. Rapid Nutrition is transitioning from a premium nutraceuticals business to a personalised, platform-led HealthTech operating model focused on evidence-based nutrition and immune wellness. Supported by an established operating portfolio, subscription-led engagement and disciplined capital allocation, the Company is further anchored by recent long-term institutional funding and is well-capitalised to execute. The Board believes the Company has reached...

New Excess Workers’ Compensation product combines specific and aggregate coverage, predictive analytics, and advanced risk management services for self-insured employers, groups, and public entities RENO, Nev., Feb. 18, 2026 (GLOBE NEWSWIRE) — Employers Holdings, Inc. (NYSE: EIG), America’s workers’ comp specialist®, today announced the launch of its new Excess Workers’ Compensation insurance product, marking a strategic expansion of EMPLOYERS’ portfolio to serve large self-insured employers, groups, pools, and joint powers authorities from coast to coast. “As the needs of employers and public entities continue to evolve, so must we,” said Katherine Antonello, President and Chief Executive Officer of Employers Holdings, Inc. “Our new Excess Workers’ Compensation insurance product represents a significant milestone in our evolution....